Barclays PLC Absci Corp Transaction History

Barclays PLC

$854 Billion
Q3 2025

A detailed history of Barclays PLC transactions in Absci Corp stock. As of the latest transaction made, Barclays PLC holds 235,380 shares of ABSI stock, worth $673,186. This represents 0.0% of its overall portfolio holdings.

Number of Shares

235,380

Previous 198,877 18.35%

Holding current value

$673,186

Previous $511,000 39.92%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$2.34 - $3.63 $85,417 - $132,505	36,503 Added 18.35%	235,380 $715,000
Q2 2025 Aug 13, 2025	BUY	$2.24 - $3.22 $211,279 - $303,713	94,321 Added 90.21%	198,877 $511,000
Q1 2025 May 15, 2025	SELL	$2.51 - $5.82 $67,915 - $157,477	-27,058 Reduced 20.56%	104,556 $263,000
Q4 2024 Feb 13, 2025	BUY	$2.55 - $4.38 $280 - $481	110 Added 0.08%	131,614 $345,000
Q3 2024 Nov 15, 2024	BUY	$2.97 - $4.49 $309,126 - $467,332	104,083 Added 379.57%	131,504 $503,000

Q2 2024 Aug 14, 2024	SELL	$2.92 - $6.58 $130,494 - $294,060	-44,690 Reduced 61.97%	27,421 $83,000
Q1 2024 May 15, 2024	BUY	$3.41 - $5.74 $245,520 - $413,280	72,000 Added 64864.86%	72,111 $410,000
Q4 2023 Feb 15, 2024	SELL	$1.15 - $4.79 $127 - $531	-111 Reduced 50.0%	111 $0
Q3 2023 Nov 07, 2023	BUY	$1.28 - $2.41 $142 - $267	111 Added 100.0%	222 $0
Q2 2023 Aug 03, 2023	SELL	$1.17 - $2.03 $31,326 - $54,353	-26,775 Reduced 99.59%	111 $0
Q1 2023 May 04, 2023	BUY	$1.58 - $3.41 $19,963 - $43,085	12,635 Added 88.66%	26,886 $46,000
Q4 2022 Feb 13, 2023	BUY	$2.0 - $3.58 $24,036 - $43,024	12,018 Added 538.2%	14,251 $29,000
Q3 2022 Nov 03, 2022	SELL	$2.95 - $4.83 $19,644 - $32,162	-6,659 Reduced 74.89%	2,233 $7,000
Q2 2022 Aug 12, 2022	SELL	$3.13 - $8.83 $26,708 - $75,346	-8,533 Reduced 48.97%	8,892 $30,000
Q1 2022 May 16, 2022	BUY	$5.87 - $9.46 $102,284 - $164,840	17,425 New	17,425 $147,000

Others Institutions Holding ABSI

# of Institutions

153

Shares Held

70.2M

Call Options Held

701K

Put Options Held

541K

View Full List

About Absci Corp

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $266M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

More about ABSI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account